. Author manuscript; available in PMC: 2020 Feb 19.

Published in final edited form as: Breast Cancer Res Treat. 2019 Sep 27;179(1):67–77. doi: 10.1007/s10549-019-05454-y

Table 1:

% tumor growth inhibition of TamR tumors over 4 weeks of treatment

days of treatment	Fulvestrant				AZD9496	GCD0310	BZA
days of treatment	25	50	100	200	AZD9496	GCD0310	BZA

0	−1%	−1%	−3%	2%	−3%	−5%	−3%
2	25%	24%	23%	28%	13%	11%	11%
4	20%	20%	20%	24%	18%	22%	23%
7	21%	26%	27%	24%	27%	28%	26%
9	18%	28%	16%	25%	24%	27%	26%
11	24%	31%	32%	39%	30%	35%	33%
14	33%	37%	44%	47%	31%	32%	31%
16	29%	40%	36%	48%	32%	42%	38%
18	39%	44%	50%	53%	36%	51%	42%
21	44%	51%	46%	61%	43%	49%	48%
23	45%	58%	53%	66%	47%	53%	48%
25	47%	59%	49%	67%	46%	53%	46%
28	47%	62%	58%	74%	43%	52%	41%